Form 4 holding
Director
Nascent Biotech Inc.
- Security class
- Common stock
- Shares / value
- 1,821,552
- Estimated value
- $182,155
- Report date
- 30 Jun 2024
- Price
- $0.1000
- Ownership
- Direct
Douglas John Karas
Insider Reports History
- Reporting-owner location
- North Palm Beach, FL
- Latest reporting-owner signature
-
/s/ Douglas Karas
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Douglas John Karas
Insider Reports Filed by Douglas John Karas
4
Nascent Biotech Inc.
- Report period
- 30 Jun 2024
- Transactions
- 1
- Transaction value
- +$5,000
- Accepted by SEC
- 02 Jul 2024, 08:51
- Role
- Director
- Next action
- Open filing details
4
Nascent Biotech Inc.
- Report period
- 31 Mar 2024
- Transactions
- 1
- Transaction value
- +$5,000
- Accepted by SEC
- 10 Apr 2024, 13:06
- Role
- Director
- Next action
- Open filing details
4
Nascent Biotech Inc.
- Report period
- 29 Dec 2023
- Transactions
- 1
- Transaction value
- +$5,208
- Accepted by SEC
- 27 Feb 2024, 13:45
- Role
- Director
- Next action
- Open filing details
4
Nascent Biotech Inc.
- Report period
- 29 Sep 2023
- Transactions
- 1
- Transaction value
- +$4,969
- Accepted by SEC
- 09 Nov 2023, 14:22
- Role
- Director
- Next action
- Open filing details
4
Nascent Biotech Inc.
- Report period
- 31 Mar 2023
- Transactions
- 1
- Transaction value
- +$5,357
- Accepted by SEC
- 09 Jun 2023, 15:28
- Role
- Director
- Next action
- Open filing details
4
Nascent Biotech Inc.
- Report period
- 30 Dec 2022
- Transactions
- 1
- Transaction value
- +$5,000
- Accepted by SEC
- 03 Jan 2023, 14:09
- Role
- Director
- Next action
- Open filing details
4
Nascent Biotech Inc.
- Report period
- 09 Mar 2022
- Transactions
- 1
- Transaction value
- +$15,000
- Accepted by SEC
- 04 Apr 2022, 16:01
- Role
- Director
- Next action
- Open filing details
4
Nascent Biotech Inc.
- Report period
- 09 Apr 2021
- Transactions
- 2
- Transaction value
- +$32,083
- Accepted by SEC
- 20 Aug 2021, 09:48
- Role
- Director
- Next action
- Open filing details